Skip to content

VIPER 286715700Recalls & reported problems

Depuy Spine, LLC · VIPER 2 SYSTEM TAP, CANNULATED AND SELF-DRILLING 7mm 30-60mm Plus or Minus 0.24 Percent · Class 1

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10705034214115), received between Jun 17, 2024 and Jun 17, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “Contamination /Decontamination Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Contamination /Decontamination Problem1

Patient problems

  • Insufficient Information1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 17, 2024Contamination /Decontamination Problem; Contamination /Decontamination Problem

    IT WAS REPORTED THAT ON (B)(6) 2024, IT WAS CONFIRMED THAT THERE WAS RESIDUAL BLOOD IN THE HOLLOW PORTION OF THE PRODUCTS IN QUESTION. THEY WERE CLEANED AND STERILIZED AGAIN AT THE HOSPITAL FOR USE ON THE FOLLOWING DAY, WEDNESDAY, (B)(6) 2024. THE FACILITY HAS A VERY HIGH LEVEL OF INFECTION AWARENESS. IT IS LIKELY TO AFFECT PRODUCT ADOPTION. THIS REPORT INVOLVES ONE (1) VIPER 2 SYSTEM TAP, CANNULATED AND SELF-DRILLING 5MM 30-60MM PLUS OR MINUS 0.24 PERCENT. THIS IS REPORT 3 OF 3 FOR (B)(4).

    Patient problems: Insufficient Information

    MAUDE report 19546659 ↗

Other TAP, BONE devices

All TAP, BONE devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.